STAT

APRIL 26, 2024

New federal rules aimed at limiting the spread of the H5N1 bird flu virus among dairy cattle go into effect Monday, but detailed guidance documents released Friday by the U.S. Department of Agriculture reveal its mandatory testing order is less stringent than initially described. While that is easing concerns from farmers and veterinarians about the economic and logistical burden of testing, it leaves questions about how effective the testing program will be at containing additional outbreaks.

Documentation 364

Documentation 364

PharmaVoice

APRIL 26, 2024

Dr. Jeremy Levin, CEO of Ovid Therapeutics, explains how scientific advances have converged to create a new era of drug development potential.

Drug Development 200

Drug Development 200

STAT

APRIL 26, 2024

On a spring afternoon in Tucson, Ariz., about a half dozen children and teens hung out in the sunny common room of Pima County’s Crisis Response Center. Beyond the pastel-painted room stretched a long, wide hall where partitions separated individual beds, many left unmade with rumpled sheets. Wearing scrubs, the kids sat in rocking chairs, watched TV, talked and laughed.

362

362

The Pharmacist

APRIL 26, 2024

Six in 10 independent pharmacy owners say that less than half of their Pharmacy First consultations pass the gateway point for a service payment, a survey has suggested. A majority of respondents said they were spending an average of 20 minutes or more on each consultation, according to the survey of 266 independent pharmacy owners […] The post Pharmacists spending time on unpaid Pharmacy First consultations, survey shows appeared first on The Pharmacist.

Independent Pharmacies 118

Independent Pharmacies 118

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

APRIL 26, 2024

Hospitals and health care systems across the United States have long been expected to provide patients with high-quality, cutting-edge care and outcomes — while staying cost-effective. Their shared mission is to continue to improve the care they provide their patients; their shared responsibility is to do so without increasing costs by shifting from fee-for-service to value-based care.

Hospitals 325

Hospitals 325

pharmaphorum

APRIL 26, 2024

Explore the latest advancements and initiatives in kidney disease research, driving change for patients with kidney conditions. Learn more about the current research landscape and potential breakthroughs in treatment from Kidney Research UK.

126

126

BioPharma Dive

APRIL 26, 2024

The Food and Drug Administration approval of Beqvez comes as other gene therapies for the bleeding condition that were approved earlier struggle to gain traction.

124

124

STAT

APRIL 26, 2024

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is likely to be low key. We plan to manicure the Pharmalot grounds, promenade with the official mascots, and catch up on our napping. We may also hold a listening party, where the rotation may include this , this , this and this.

Biosimilars 286

Biosimilars Specialty Pharmacies Hospitals 286

The Pharmacist

APRIL 26, 2024

A tool that calculates the carbon footprint of medicines has launched after being awarded £730,000 in funding through the Small Business Research Initiative (SBRI). Sustainable medicines company YewMaker has created the Medicines Carbon Footprint (MCF) formulary, a free tool which provides the per dose carbon footprints for over 4,000 medicines. Users can compare the medicine carbon […] The post Tool detailing carbon footprint of medicines launches appeared first on The Pharmacist.

111

111

STAT

APRIL 26, 2024

WASHINGTON — A House committee next month plans to mark up legislation that would restrict U.S. biotechnology companies from doing business with a Chinese company that makes key drug ingredients, according to five lobbyists tracking the BIOSECURE Act. The goal is for the House to pass the bill before the July 4 recess, setting it up to be included in a year-end must-pass legislative package.

Packaging 291

Packaging 291

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

APRIL 26, 2024

Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and Melinda Gates Foundation, for development of breath-based diagnostic solutions to improve outcomes in the developing world.

116

116

STAT

APRIL 26, 2024

MultiPlan is facing a new class action lawsuit that alleges the company and large health insurers “conspired to fix, suppress, and stabilize” payments made for out-of-network medical claims. The lawsuit, filed by for-profit hospital company Allegiance Health Management, builds on the contentious relationship between hospitals and MultiPlan, a data technology vendor that works with the biggest insurers to determine how much should be paid for care that is delivered outside of an ins

Hospitals 299

Hospitals 299

European Pharmaceutical Review

APRIL 26, 2024

A paper has reported the first time that 3D printing has facilitated two active pharmaceutical ingredients (APIs) to be combined in the same formulation. This method enables the number of administrations of the drug evaluated to be minimised, the researchers found. The authors aimed to evaluate and compare the efficacy and acceptability of chewable 3D printed medicines containing citrulline, isoleucine, and valine alone or in combination.

Compounding 110

Compounding Hospitals 110

STAT

APRIL 26, 2024

It’s another busy day in my spine surgery clinic when my phone rings. Patients are waiting, but I’d be unwise to put off the caller: a physician calling from a health insurance company. This peer-to-peer call is part of the prior authorization process; my “peer” needs information to determine whether the company will cover a procedure I requested for one of my patients.

Health Insurance Companies 290

Health Insurance Companies 290

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

APRIL 26, 2024

In an ambitious move, Moderna has teamed up with OpenAI, the artificial intelligence company behind ChatGPT, to further integrate generative AI (GenAI) across its mRNA drug development and manufacturing operations.

Drug Development 111

Drug Development 111

STAT

APRIL 26, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

250

250

The Pharmacist

APRIL 26, 2024

Just one IT provider is believed to have rolled out updates to allow pharmacies to send structured records of Pharmacy First consultations to GP practices, The Pharmacist understands. At the time of writing Cegedim Rx was understood to be the only supplier to have gone live with GP Connect's Update Record integration so far, despite […] The post Just one pharmacy IT supplier has enabled integrated Pharmacy First GP updates appeared first on The Pharmacist.

97

97

European Pharmaceutical Review

APRIL 26, 2024

AbbVie has revealed positive topline results from the first head-to-head trial in atopic dermatitis assessing RINVOQ ® (upadacitinib) at a starting dose of 15mg daily versus DUPIXENT ® ( dupilumab ) at its labelled dose. The Phase IIIb/IV LEVEL UP study evaluated the efficacy and safety of these drugs in individuals 12 years old and older with moderate-to-severe atopic dermatitis.

Labelling 98

Labelling 98

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

APRIL 26, 2024

Under the collaboration, Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform (AIP) to further power its clinical data platform, focused on driving clinical trial efficiency while maintaining the safety and regulatory rigor Parexel and Palantir Technologies has announced a multi-year strategic partnership to leverage AI to help enhance and accelerate the delivery of safe and effective clinical trials for the world’s biopharma customers.

Drug Development 103

Drug Development 103

pharmaphorum

APRIL 26, 2024

Chemists at ETH Zurich have developed a new computer process that enables the generation of active pharmaceutical ingredients at speed, based on a protein’s three-dimensional surface.

105

105

Pharma Times

APRIL 26, 2024

The paper identifies the roles of LARP4A and LARP4B in sarcoma and carcinoma cancers

124

124

World Pharma News

APRIL 26, 2024

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes, and do not have neutralizing antibodies to adeno-associated virus serotype Rh74var (AAVRh74var) capsid as detected by an F

84

84

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

APRIL 26, 2024

The new method could help to prevent severe side effects caused by enantiomer drugs

111

111

pharmaphorum

APRIL 26, 2024

Merino Perugini from Nestlé Health Science sat down for an exclusive interview with Jonah Comstock from Reuters Pharma USA to discuss the company's latest innovations and successes in the healthcare industry. Get insights into their strategies and future plans.

72

72

Big Molecule Watch

APRIL 26, 2024

On April 23, 2024, Alvotech announced “positive topline results from a confirmatory clinical study for AVT05,” Alvotech’s proposed golimumab biosimilar to Janssen Biotech, Inc.’s SIMPONI (R) and SIMPONI ARIA (R). According to Alvotech, the confirmatory clinical study (NCT05842213) was a randomized, double-blind, two-arm, multicenter clinical study designed to investigate the therapeutic equivalency of AVT05 and SIMPONI (R) for the treatment of rheumatoid arthritis.

Biosimilars 70

Biosimilars 70

Drug Channels

APRIL 26, 2024

Today’s guest post comes from Kevin Kettler, President of CoverMyMeds. Kevin asks: What if there were no barriers across the therapy access and reimbursement process? In his view, eliminating barriers requires a combination of expert insight, actionable data, and simplification of the providers' experiences. Click here to learn more about CoverMyMeds’ comprehensive technology solutions.

70

70

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

PharmaTech

APRIL 26, 2024

As breakthrough therapeutics in the pharma pipeline approach commercialization, pharmaceutical manufacturing facilities must evolve to meet demand.

Pharmaceutical Manufacturing 72

Pharmaceutical Manufacturing 72

Pharmafile

APRIL 26, 2024

ANGLE has announced that it has signed a supplier agreement with AstraZeneca for the development and validation of a methodology which will leverage ANGLE’s existing DNA damage response (DDR) assay for the detection of micronuclei in circulating tumour cells (CTCs) as a measure of DDR. The post ANGLE signs commercial agreement with AstraZeneca appeared first on Pharmafile.

64

64

Outsourcing Pharma

APRIL 26, 2024

In an extensive and enlightening chat with Prasad Rajeev, the CEO of LGM Pharma, OSP gained profound insights into the company's trajectory within the pharmaceutical industry.

63

63

Pharmafile

APRIL 26, 2024

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration for the research, development and commercialisation of in vivo CRISPR-based gene editing therapies for multiple tissue and cell types. The post Regeneron and Mammoth Biosciences announce CRISPR collaboration appeared first on Pharmafile.

64

64

BioPharma Dive

APRIL 26, 2024

Prescription volume erosion is tracking with company forecasts, executives claimed, even as more insurers could exclude the branded drug.

Biosimilars 75

Biosimilars 75